SHOW / EPISODE

Eden Research Sean Smith discusses Mevalone approved in 17 US states and Cedroz in 8

6m | Mar 24, 2023

Eden Research (LON:EDEN) CEO Sean Smith joins DirectorsTalk Interviews to discuss regulatory approval for its formulated products Mevalone® and Cedroz™.


Sean explains why they need 'state approval' when it was already announced that they had 'national approval', with California being one of the most important states the impact not yet having approval has on the business, when to expect approval and what else the company is expecting in terms of regulatory approvals.


EDEN RESEARCH IS FOCUSED ON SUSTAINABLE BIOPESTICIDES AND PLASTIC-FREE ENCAPSULATION TECHNOLOGY FOR USE IN GLOBAL CROP PROTECTION, ANIMAL HEALTH AND CONSUMER PRODUCTS INDUSTRIES.

Audio Player Image
DirectorsTalk Interviews
Loading...